Skip to content
Markets News
Stocks1 min read

Bavarian Nordic Wins Four-Year UK Vaccine Supply Contract

Makkler Newsroom
November 2, 2026 · Based on reporting by GlobeNewswire

The agreement covers scheduled deliveries of the company’s MVA-BN vaccine, with optional flexibility provisions over the contract term.

Key takeaways

  • The UK awarded Bavarian Nordic a four-year vaccine supply contract.
  • The agreement covers scheduled MVA-BN deliveries and includes optional flexibility provisions.

Bavarian Nordic has been awarded a four-year contract by the UK government to supply its MVA-BN vaccine, the company said Monday.

The agreement was awarded through the UK Health Security Agency. Deliveries are scheduled across the contract term, which also includes optional flexibility provisions.

MVA-BN is a non-replicating vaccine indicated for the prevention of mpox and smallpox. Bavarian Nordic said the contract supports the UK’s long-term preparedness for infectious disease threats.

Topics
BAVAUK GovernmentUK Health Security Agency
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.